Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2,564.87 | N/A |
PEG Ratio (TTM) | 26.25 | N/A |
P/S Ratio (TTM) | 1.34 | N/A |
P/B Ratio (TTM) | -946.81 | N/A |
P/FCF Ratio (TTM) | -1.51 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -34.04% | N/A |
ROE (TTM) | 393.06% | N/A |
Net Profit Margin (TTM) | -84.14% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 87.30% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -231.74% | N/A | N/A |
Cash Flow | -660.13% | N/A | N/A |
Health (11%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.47 | N/A |
Quick Ratio (TTM) | 0.47 | N/A |
D/E Ratio (TTM) | -0.33 | N/A |
Interest Coverage (TTM) | 20.35 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |